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I NTRODU CTl ON 
Herpes esophagitis (HE) was first described by Pearce 
and Uagradi in 1943 [I]. For 30 years the diagnoses 
were made in post niortern studies of immuno- 
compromised patients 12-41. Then, the developement 
of endoscopy allowed an earlier diagnosis [5,6]. 
HE is a well-known complication of imniuno- 
depression, and the esophagus is the viscus most often 
involved during the dissemination of herpes simplex 
virus (HSV) infection 171. HE is observed in up to 5% 
of patients treated for malignant hematologic diseases 
[8], 1-6% of solid organ transplant recipients [9,10] and 
10-1 5% of bone marrow-transplanted patients [ l l ] .  
HE is also an AIDS-defining condition [12] and a 
frequent site of disseminated neonatal HSV infection 
[13,14]. Interestingly, HE has also been anecdotically 
described in imniunocoinpetent patients, in whom it is 
a self-limited illness [15]. We give here an extensive 
review of HE, including its pathophysiology, clinical 
manifestations, treatment and outcome. 
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POPULATIONS AT RISK 
Several types of immunodeficiencies have been 
described as risk factors for HE (Table l ) ,  but cellular 
iniinunity is the key factor for the control of herpes 
simplex infection, while the role of antibodies and 
complement is less important [I 6,171. Thus, patients 
with quantitative defects of T-lymphocytes are particu- 
larly prone to develop HSV infections. Indeed, we 
recently reported such a complication during the late 
stages of HIV infection [18]. Qualitative defects of T- 
lymphocytes also represent a risk factor; this is parti- 
cularly true for liver and renal transplant patients [19]. 
Furthermore, cellular immunodepression favors the 
presence of HSV in the saliva [ZO], which may be a 
potential source of esophageal infection during swallow- 
ing [7,21]. 
Corticosteroids and anticancer chemotherapy are 
also well-known risk factors for visceral HSV infection 
[7]. Indeed, corticosteroids are able to inhibit the 
activation, proliferation, differentiation and functions 
of virtually all cells involved in the immune response, 
but particularly T-cell proliferation [22-241. Anti-  
cancer chemotherapy and radiotherapy have imniuno- 
suppressive effects but are also associated with the 
loss of normal esophageal mucosal integrity, which 
enhances the risk of HSV reactivation [25]. 
Previous upper digestive tract endoscopy or 
insertion of gastric tube are reported in 33-7 1% of cases 
during the weeks before HE [4,7,18,26]. Nasogastric 
intubation may favor the development of HE by 
trauma and/or viral autoinoculation 17,271. However, 
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Table 1 Populations at risk for HE 
Hematologic malignancies, with or without neutropenia 
[6-8,27,62,65,75,79,82,87,95,97,102,107.109,117,118] 
Solid tumors [3,7,27,57,62,65,68,78,87,88,97,102,107,116, 
Systemic or inflanimatory diseases [24]: systemic lupus 
erytheniatosus [62,120,121], 
119,120] 
Wegener’s granulomatosis [7,62], polyarteritis nodosa [7], 
giant cell arteritis [27], rheumatoid arthritis [27,68.75,102], 
polymyositis [102], Crohn’s disease [7,62], ulcerative colitis 
[57], rapidly progressive glomerulonephritis [7], tuberculosis [2] 
HIV infection [18,27,38-44,62,55,92,102,107,109,120] 
Extensive burns (271-Recent trauma (71 
Alcoholism [102,120] 
Diabetes mellitus [27,57,102,120,122] 
Cystic fibrosis [lZO] 
Heart insufficiency [57] 
Renal insufficiency 1781 
Gastro-esophageal acid reflux [29,78,120] 
Mental retardation [123] 
Iatrogenic factors 
Radiation therapy (particularly for mediastinal tumors) 
[6,27,75,87,102,119] 
Solid organ transplantation-cyclosporin [ 19,Z7,62,107,124-127] 
Bone marrow transplantation [80,95,102,109] 
Anti-CD3 monoclonal antibodies [32] 
Immunosuppressive agents: cyclophosphamide, azathioprine 
[68,120] 
Systemic steroid therapy [27,57,68,75,87,102,120,12 11 
Inhaled steroids [128] 
Recent surgery [129]-trigeminal nerve surgery [21] 
no definitive conclusion concerning its role in favoring 
HE can be drawn in the absence of case-control 
studies in immunocompromised patients. Endotracheal 
intubation and nasogastric tubes should be avoided in 
such patients in case of patent labial or buccal herpetic 
infection [28]. Gastroesophageal reflux has also been 
cited as a possible risk factor for HE [29]. 
Herpes esophagitis in solid organ transplant recipients [281 
HSV reactivation is mostly observed during the first 
month post-transplantation, and HSV infections occur 
within the first 2 months after transplantation [30]. In 
a prospective study of infectious esophagitis following 
liver and renal transplantation, the authors discovered 
HE in 3/47 liver transplants post-transplantation (6%) 
and in 1/21 renal transplants post-transplantation (5%). 
These data showed a lower prevalence of HE than that 
observed after marrow transplantation [11,31]. In the 
latter paper [31], no association between HE and 
administration of prednisone or blood level of cyclo- 
sporin A was found. HE has also been reported after 
cardiac transplantation, but no clear data on the pre- 
valence were reported [lo]. Mter transplantation, the 
use of anti-CD3 monoclonal antibodies has also been 
associated with an increased frequency of HSV reacti- 
vation, including HE [32]. 
Herpes esophagitis during bone marrow transplantation 
There is no  significant difference in HE incidence 
between autologous and allografted bone marrow 
recipients [33]. Prior to the prophylactic use of acyclovir, 
80% of seropositive patients excreted HSV during the 
first SO days after bone marrow transplantation, with a 
peak excretion during the second or third week 1331. 
By contrast, fewer than 2% of seronegative patients 
excrete HSV after transplantation, suggesting that 
HSV infection after transplantation is mostly due to 
reactivation [33,34]. During a prospective study of 44 
episodes of unexplained nausea and vomiting after 
allogeneic bone marrow transplantation, Spencer et a1 
[31] documented HE in five cases occurring 1-4 
months after transplantation. HSV infection was less 
common than cytomegalovirus (CMV) infection in 
two series [11,31], probably because of the frequent 
use of prophylactic acyclovir. Among 39 bone marrow 
transplant recipients, 21 had infectious esophagitis, 
including six isolated HE cases and four co-infections 
with CMV or Candida sp. HE occurred mostly in non- 
neutropenic patients within a mean of 72 days after 
transplantation and earlier than fungal esophagitis [ 1 11. 
Surveillance cultures of the oropharynx obtained 1-7 
days before the endoscopy were not useful in predicting 
the organism causing esophagitis [ l  11. Three of six 
patients with HE died without resolution of their 
esophagitis. The same authors reported postmortem 
data showing evidence of esophageal infection in 25/59 
patients, including six due to HSV [ l l ] .  In the 
neutropenic population, herpetic ulcerations have been 
reported to be a portal of entry for various bacterial and 
fungal infections [35]. 
Herpes esophagitis in AIDS patients 
During HIV infection, HSV seroprevalence is 80-95% 
for type 1 and 20-30% for type 2 [36]. HIV and HSV- 
1 enhance reciprocally their replication in macrophages 
and keratinocytes [37]. During HIV-1 infection, HE 
has been considered to be relatively uncommon and 
classically less frequent than esophagitis due to CMV 
[38-401, in contrast to results reported in other studies 
[41-431. In HIV-1 patients, HE was the cause of4-16% 
of esophageal symptoms [38,39,41-431 and occurred in 
four out of 154 patients (2.5%) followed prospectively 
[43]. We recently reported 34 AIDS patients with HE 
[18]. In that paper, the mean CD4 cell count was 
15/mm3 and recent predisposing factors (nasogastric 
procedures, steroid therapy, anticancer therapy) were 
noted in 47% of patients. Only 15% of our patients 
relapsed, most of them having an iatrogenic pre- 
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disposing factor (steroids, anticancer therapy). HE has 
also been reported during HIV primary infection [44]. 
Herpes esophagitis during disseminated neonatal HSV 
infection 
In neonates, the esophagus is frequently involved in 
the dissemination of HSV infection 1141. The exact 
prevalence has not been precisely described, but histo- 
logic changes consistent with HE were demonstrated 
in up to 75% of fatal cases [45]. In the absence of skin 
vesicles (20%), the clinical signs of disseminated HSV 
infection are often non-specific, mimicking those of 
neonatal bacterial sepsis 1141. HE by itself may be 
responsible for feeding difficulties, deglution disorders, 
hypersalivation, glottic edema and vomiting 1461. 
Herpes esophagitis in immunocompetent patients 
HE may occur in immunocompetent patients [15,29, 
47-68]. I11 such cases, HE is similar to that occurring 
in ininiunocomproniised patients, but is rarely diffuse 
and necrotic [55]. It spontaneously disappears within a 
few days or weeks, but esophageal recurrence has been 
described [55]. Because HE occurring in immuno- 
competent patients may be paucisymptomatic, it is 
probably underdiagnosed 155,601. 
PATHOGENIC MECHANISMS OF ESOPHAGEAL 
INVOLVEMENT 
The factors that determine HSV-1 virulence in humans 
are not known, although experimental models have 
helped in deciphering host genetic and immune 
factors, as well as viral genes conferring increased 
virulence. Herpes simplex viremia has not been docu- 
mented in adults, and does not represent a significant 
route of viral replication. However, viremia occurs in 
neonates infected at birth with HSV-2 [69], and has 
been reported in HSV-1-infected children receiving 
immunosuppressive therapy [70]. Therefore, esophageal 
infection is most often secondary to a viral recurrence, 
most of the time by regional extension of buccal or 
pulmonary localization 1711. It is now well established 
that after infection of the oral epithelium, viral particles 
are taken up by the peripheral nerve endings of sensory 
neurons that innervate the primary site of infection, 
and are transported by retroaxonal axoplasniic flow to 
the neuronal bodies, located in the sensory ganglia. 
Latent virus has been detected in the nodose ganglia 
innervating the gastrointestinal tract [72]. Experimental 
niurine models have clearly shown that oral HSV-1 
inoculation in the esophageal lumen leads to latency in 
the sensory ganglion of the tenth cranial nerve [73]. 
Furthermore, HSV-1 was shown to spread considerably 
through all levels of the enteric nervous system, infect- 
ing niucosal nerve fibers directly in contact with the 
epithelium 1741. These findings might explain why 
HSV is a frequent cause of recurrent esophageal disease 
in humans. 
The respective roles of HSV-1 and HSV-2, primary 
infection and recurrence, and the main mechanisms 
explaining the esophageal localization, are summarized 
in Table 2. In adults, HE is niostly caused by HSV-1 
[15,55,57,75], but HSV-2 may also seldom be incrimi- 
nated [ 761. 
CLINICAL FEATURES 
HE symptomatology is protean [62]. Major symptoms 
are dysphagia and esophageal pain. The main clinical 
Table 2 Pathophysiology of herpes esophagitis 
Main Mcchanisiiis of 
pathogenic e~ophageal 
Populatioii Virus mechanism localization 
Neonates [14] HSV-2 
IIniiiunocoiiipetent 
children and adults HSV-1 
Iinniuiioc-oiiipromised patients [I 1 I] 
Hematologic 
malignancies or solid 
organ transplantation HSV-la 
AIDS 1181 HSV-la 
Primary infection 
Primary infection 
Kecurrence" 
Recurrence 
Vireniia 
Multi-organ extension 
Regional extemion 
Regional extension 
Multi-organ extciision 
Regional extension 
'HSV-2 anecdotally 
hMay occationally be a primary infection, transmitted by direct person-to-person contact or via the allograft [I 301 
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symptoms reported during large series of HE [18, 
62,771 are mentioned in Table 3. Chest pain or upper 
digestive tract hemorrhage may reveal HE [78,79], the 
latter being reported in 11-25% of the cases [18,62]. 
Chronic hiccups is rarely described during HE [18,80]. 
Postmortem and endoscopic series clearly denion- 
strated that HE may be asymptomatic [3,4,18]. Ulcer- 
ative oropharyngeal mucosal lesions are inconstantly 
present (12-38% of cases) [18,77] but may contribute 
to the diagnosis in patients with esophageal symptoms. 
Therefore, the absence of mucocutaneous herpes does 
not in any way rule out the diagnosis of HE. HE may 
be associated with other HSV visceral localizations in 
patients with hematologic malignancies 171, in neonates 
[7,62] and in patients who have undergone solid organ 
transplantation [81], but, interestingly, not in AIDS 
[18l. 
RADIOLOGY 
Barium esophagography should include simple and 
double contrasted films [65,82,83]. Small ulcerations 
which predominate in the distal part of the esophagus 
are the most typical radiologic features [65,84-861. 
However, radiologic aspects are often less specific 
[27,55,87]. Indeed, large ulcers indistinguishable from 
those observed in fungal esophagitis have also been 
reported [86,88]. 
ENDOSCOPY 
Since confirmation of diagnosis is obtained by histology 
or culture of esophageal specimens, endoscopic exami- 
nation must be carried out [55,87,89]. It can be done 
first when a patient complains of odynophagia suggestive 
of ulcerated esophageal lesions, or after the failure of an 
empirical systemic anticandidiasis treatment, as recently 
proposed for AIDS patients [90]. 
The classic predominance of lesions in the lower 
half of the esophagus in inimunocompromised patients 
[75] was confirmed in AIDS patients [18]; indeed, the 
lower third was affected in 50% of the cases, the median 
third in 12% and the upper third in only one case. In 
one-third of these cases, lesions were spread throughout 
the entire esophagus. 
The most typical macroscopic appearance is only 
seen during early HE, with vesicles and/or volcano 
ulcers whose size varies from a few millimeters up to 
2 cni. Later in the evolution, they may coalesce, and 
the mucosa becomes friable with diffuse erosions 
and/or superficial potentially hemorrhagic ulcers [l 1, 
62,75,77]. 
Diffuse superficial ulcers encountered in the 
majority of HE cases help to distinguish HE from 
CMV, which causes deeper ulcerations [87,91]. Non- 
ulcerated erytheniatous esophagitis is nonetheless 
possible but rare; it was found in 9% of our AIDS 
patients [ 1 81. The presence of pseudomembranes 
without esophageal candidiasis, and bullous esophagitis, 
has also been described with HSV [11,18,62]. Anec- 
dotically, ulcerated exophytic stenosis [18], tracheo- 
esophageal fistula 1921, spontaneous esophageal per- 
foration [93] and aspects mimicking a lye burn in a 
child [61] have been reported in isolated case reports. 
Margins of esophageal ulcers and islands of 
squamous epithelium have to be biopsied and brushed 
[77,94]. Indeed, biopsies of the ulcer’s base are usually 
non-diagnostic [77]. Interestingly, HE may be un- 
suspected eiidoscopically in several patients [ 18,771, 
confirming the need for biopsies and brushing in 
inimunocompromised patients with esophageal synip- 
toms [62]. The association of HE with herpetic gastritis 
Table 3 Clinical symptoms of herpes esophagitis 
GCnCreau [ 181 McBane 1621 Baehr [771 
(n=34) (n=23) (n=48) 
Underlying 
conditions (96) 
Dysphagia 
Odynophagia 
Chest pain 
Fever 
Extraesophdgeal herpes 
Nausea/vomiting 
Digestive hemorrhage 
Hypersalivation 
Chronic hiccups 
Asymptomatic 
AIDS (100) 
84% 
7 2% 
72% 
39% 
33% 
30% 
9% 
6% 
3% 
6%) 
Malignancies (52) 
Innnunodepression (48) 
52% 
52% 
56% 
35% 
35% 
39% 
34% 
0% 
Inimunodepression (100) 
79% 
79% 
4% 
29% 
15% 
G e n e r e a u  e t  a l :  H e r p e s  e s o p h a g i t i s  40 1 
is rare [95], as viral ulcers are most often located only 
in the Malphigian epithelium and thus above the 
esophagogastric junction. 
In  iiiirnunoconiproniised patients, HE may be 
associated with various opportunistic diseases such as 
candidiasis, CMV and Kaposi’s sarconia [18,57,62,87]. 
Finally, HE can disappear with fibrous scarring and 
subsequent esophageal stenosis that may necessitate 
dilatation [ 13 I .  
HISTOLOGY 
Brush cytology is very useful for HE diagnosis 196-981, 
and niay also help in the diagnosis of esophageal 
candidiasis [97]. Cytologic preparations have better 
cell preservation, and inay provide a more definitive 
diagnosis [97]. The most typical cytologic aspects are 
ground-glass nuclei and inultinuclear giant cells [96]. 
Brushing allows the sampling of larger areas than 
biopsies 1971, and was sometimes reported to be more 
useful than histology [87], with a definitive diagnosis in 
20-100%1 of cases. 
Histologic studies should be performed on 
formaldehyde-fixed, paraffin-embedded biopsy samples 
stained with hematoxylin-eosin and Gienisa. Grocott’s 
methenaiiiine silver and periodic acid-Schiff are neces- 
sary to eliminate the diagnosis of fungal esophagitis. 
Typical HE pathologic changes are mostly found only 
at the edge of ulcers [99]. 
Characteristic histopathologic aspects found by 
light microscopy include ballooning degeneration, 
ground-glass nuclei with marginated chromatin and 
eosinophilic nuclear inclusions (Cowdry type A 
inclusions) of squamous epithelial cells as well as 
niultinuclear giant cells [99]. Typical Cowdry A in- 
clusions are rarely encountered when samples are riot 
fixed in Zencker’s acetic acid or Bouin’s solution [99]. 
By electron microscopy, they appear to be para- 
crystalline viral structures [94,100,101]. Giant cells and 
sinall coniplexes of squamous cells are niostly seen on 
the epithelial border of the ulcer [99]. 
lntranuclear inclusions cannot differentiate between 
HSV and varicella-zoster infections, but in the absence 
of disseminated pox, these inclusions are highly 
suggestive of HE [97]. Ground-glass nuclei can also be 
observed during CMV esophagitis; however, during 
the latter they also involve mesenchymal and glandular 
epithelial cells [99]. The floor of the ulcer contains 
inflammatory cells, fibrin and necrotic debris 1991. 
When typical herpetic changes are not seen, aggregates 
of large mononuclear cells (mostly CDh8-positive 
macrophages and activated T-cells) [lo21 with con- 
voluted nuclei are also characteristic of HE [102]. 
Histolog allowed a definitive diagnosis in 40-67‘%1 of 
the cases [11,18,94]. 
Iiiiiiiunohistocheniistry [09,103], immunofluor- 
escence [104], in situ hybridization (ISH) 1103, 1051, 
or in situ polynierase chain reaction may be warranted 
when the herpetic nature of ulcerated esophagitis has 
not been demonstrated by standard techniques [ 1031. 
ISH (using biotinylated .probes) and immunohisto- 
cheiiiistry are used to rapidly detect viral nucleic acids 
in formalin-fixed, paraffin-embedded tissues [ 1031. 
These two methods appear equally effective for the 
diagnosis of HE, and their results are better correlated 
with the presence of viral inclusions than with culture 
results [103]. ISH stains are more difficult to inter- 
pret; thus immunohistocheniistry, which is also less 
expensive than ISH, may be preferable for routine 
clinical practice work [103]. Furthermore, the presence 
of the HSV genome within a cell without viral 
inclusions or iiiiniuriohistoclieiiiical or histologic 
changes should be interpreted with caution [ I  Oh]. 
Iminunohistocheniistry results may disclose granular to 
homogeneous reaction product within the nuclei and 
the cytoplasm of squamous cells infected by HSV 1991. 
The normal esophageal squanious epithelium at some 
distance from the ulcer, as well as inflammatory and 
niesenchynial cells, does not stain with anti-HSV 1991. 
In some cases, histologic and ultrastructural studies 
may disclose mixed viral and fungal esophageal infect- 
ions [loo]. 
VIROLOGY 
The most sensitive and specific diagnostic niethod for 
confirming HSV infection remains isolation of the 
virus from tissue cultures [10,81]. Indeed, it allowed a 
definitive diagnosis in 70-100% of the cases [l 1,18, 
62,941. Specimens must be transported to the labora- 
tory in virus-stabilizing media [81] and cultured by 
inoculation onto human embryonic lung fibroblasts or 
rabbit kidney cells. Viruses are identified by typical 
cytopathic changes, in most samples within 48-96 h 
after inoculation. HSV can be identified rapidly by 
imiiiunohistochemical staining of a centrifuged culture 
suspension after 24-36 h [77]. Virus isolation also 
allows subtyping, gene sequence mapping and antiviral 
sensitivity testing [81]. 
DIAGNOSTIC STRATEGY 
The diagnostic evaluation of an initnunodepressed 
patient with esophageal symptoms should involve both 
histology and viral esophageal cultures, whose conibina- 
tion gives the better diagnostic value. However, the 
exact sensitivity and specificity of all these methods are 
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Table 4 Major differential diagnoses of herpes esophagitis 
Esophageal infections [77,131] 
Common infections 
Caridida albicanr [91,132] 
Cytomegalovirus [91,132-1341 
Human immunodeficiency virus [135-1371 
Epstein-Barr virus [138] 
Herpes zoster [139] 
Papilloma virus [14OJ 
Mycobacterium tnberrulosis [141-1431 
M. avium intracellulare complex [43] 
Bacteria from the oral flora (1441 
Nocardia asteroidex [145] 
Eeponema p a l l i d m  (tertiary syphilis) [1461 
Helicobacter pylori [ 1471 
Aspergillus sp. [148] 
Histoplasma capsztlatum [149] 
Tomloppsis Qlabrata [15O] 
Cryptosporidium [151] 
Pnenmocystir rarinii [152] 
Leishmania donovani [153] 
AIDS-related idiopathic ulcers 1154,1551 
Uncommon infections 
Malignancies 
Kaposi’s sarcoma [91] 
Malignant lymphoma [91] 
Carcinoma-sarcoma 
Peptic esophagitis 
Medications [156] 
Common: tetracyclines, potassium, quinidine, aspirin and 
Uncommon: zidovudine [157], iron, clindamycin, captopril, 
non-steroidal anti-inflammatory drugs 
theophyllin, ascorbic acid, alendronate [I581 
still questionable, as they have not been studied with 
adequate methodology. As all of the above described 
diagnostic methods may be falsely negative, suspected 
HE may be finally confirmed by the efficacy of the 
acyclovir therapeutic test [18,107]. 
Finally, it has to be noted that the detection of anti- 
HSV antibodies does not have any clinical utility for the 
diagnosis of HE in immunocompromised individuals 
[108]. Major differential diagnoses of HE are described 
in Table 4. 
TREATMENT 
Although HE may resolve spontaneously, in immuno- 
competent [66] but also in immunodepressed patients 
[lS], antiviral treatment is always indicated to prevent 
the diffusion of the infection, and/or to limit the risk 
of dehydration, malnutrition and local sequelae. 
Acyclovir remains the treatment of choice for HE, 
although very few controlled studies are available. Oral 
administration seems as efficient as the intravenous 
route, but is frequently impossible because of dysphagia, 
odynophagia and vomiting. Intravenous administration 
(15 mg/kg/day or 250 mg/m2/day) is usually rapidly 
effective in solid organ transplant recipients [28], 
AIDS patients [18] or marrow transplant recipients 
[33]. In immunodepressed patients, treatment failure 
may be explained by esophageal co-infections or other 
esophageal disease [18,31]. 
Some HE may be due to acyclovir-resistant viral 
strains [109,110], more frequently in patients who have 
been repeatedly exposed to this drug [ l l l ] .  Such cases 
should be treated with foscarnet [112], which is 
superior to vidarabine for acyclovir-resistant muco- 
cutaneous herpes infections in AIDS [113]. 
Primary prophylactic acyclovir treatment can be 
considered in high-risk immunodepressed patients, but 
not in AIDS patients. Indeed, when given 3 days before 
bone marrow transplantation, it prevented HSV 
reactivation and reduced the incidence of HSV 
infections from 50-80% to less than 10% [114,115]. 
In AIDS, HE recurrences are uncommon [18] and 
suppressive therapy should not be systematically pre- 
scribed. However, in cases of frequent or severe 
recurrences, a preventive regimen (600-1000 mg in 
3-5 divided oral doses per day) may be administered 
[116]. 
CONCLUSION 
HE is common in immunocompromised patients and 
should be systematically suspected in cases of odyno- 
phagia, chest pain, unexplained nausea or upper 
digestive tract bleeding. Most of the time, HE results 
from HSV-1 reactivation and the regional extension of 
an oral or pulmonary infection. Diagnosis is suggested 
through endoscopy, which usually displays ulcerated 
esophagitis predominantly in the lower third. The 
combination of brush cytology, histology and viral 
cultures allows the best diagnostic sensitivity. Empirical 
acyclovir treatment also allows a presumptive diagnosis 
when it is rapidly effective. Finally, HE most often 
presents as a benign condition when it is diagnosed 
early and treated. 
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